Convalescent plasma as a potential therapy for COVID-19
- PMID: 32113510
- PMCID: PMC7128218
- DOI: 10.1016/S1473-3099(20)30141-9
Convalescent plasma as a potential therapy for COVID-19
Comment in
-
Appropriate selection of convalescent plasma donors for COVID-19.Lancet Infect Dis. 2021 Feb;21(2):168-169. doi: 10.1016/S1473-3099(20)30470-9. Epub 2020 Jun 15. Lancet Infect Dis. 2021. PMID: 32553190 Free PMC article. No abstract available.
Comment on
-
The effectiveness of convalescent plasma and hyperimmune immunoglobulin for the treatment of severe acute respiratory infections of viral etiology: a systematic review and exploratory meta-analysis.J Infect Dis. 2015 Jan 1;211(1):80-90. doi: 10.1093/infdis/jiu396. Epub 2014 Jul 16. J Infect Dis. 2015. PMID: 25030060 Free PMC article.
References
-
- WHO Use of convalescent whole blood or plasma collected from patients recovered from Ebola virus disease for transfusion, as an empirical treatment during outbreaks. 2014. http://apps.who.int/iris/rest/bitstreams/604045/retrieve
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical